Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 79953724Search this ID in NIH RePORTER
- ScienceDex PI coverage
- FY2024 onlyCareer claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
NIH Funding · FY2024
Linked Award Amount
$5.9M
Full award amounts, FY2024
Award Records
4
Records listing this PI
Award-Linked Rank
#854
By linked amount among FY2024 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage
Award data coverage
ScienceDex currently has one fiscal year of PI ranking data for this record. This does not establish the first NIH award or current employer.
Single fiscal year on record (FY2024): $5.9M in linked award amounts across 4 award records · Award-linked rank #854.
FY2024 award records by amount
NIH award records listing Dennis Eyler as a PI. Multi-PI records show the full award amount for context.
- 75N93022C00023-P00003-9999-3N01Division of Microbiology and Infectious Diseases (DMID): Clinical Materials Services (CMS)$4.2Maward amount
- 75N93022C00023-P00003-9999-4N01Division of Microbiology and Infectious Diseases (DMID): Clinical Materials Services (CMS): mpox Studies$1Maward amount
- 75N93022C00023-P00003-9999-1N01Division of Microbiology and Infectious Diseases (DMID): Clinical Materials Services (CMS), SARS-CoV-2$500Kaward amount
- 75N93022C00023-P00003-9999-2N01Division of Microbiology and Infectious Diseases (DMID) Clinical Materials Services: Antibiotic Resistant Clinical Studies$200Kaward amount
Award organization
Organizations that administered FY2024 awards listing Dennis Eyler as a PI.
FY2024 award administered by Fisher Bioservices, Inc. (MD).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardFisher Bioservices, Inc.
- 2024$500K Cumulative Funding
- 2024$1M Cumulative Funding
- 2024$2M Cumulative Funding
- 2024$5M Cumulative Funding
- 2024Entered Top 50% NationallyRanked #854
- 2024Entered Top 25% NationallyRanked #854
- 2024Entered Top 10% NationallyRanked #854
- 2024Entered Top 5% NationallyRanked #854